Liechtenstein vs San Marino: Survival to age 65, female
Liechtenstein
94.6%
in 2024
San Marino
95.1%
in 2024
Liechtenstein rank
10th
San Marino rank
7th
Survival to age 65, female over time
- Liechtenstein
- San Marino
How they compare
San Marino currently reports 95.1% against 94.6% in Liechtenstein, a difference of 0.5%.
The two have swapped places 4 times across 65 shared years of data; in 1960 it was San Marino ahead.
Liechtenstein ranks 10th and San Marino ranks 7th of 218 countries.
Across the 7 decades both report, Liechtenstein averaged higher in 1 and San Marino in 6.
Head to head by decade
| Decade | Liechtenstein | San Marino | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 83.2% | 86.4% | 3.2% | San Marino |
| 1970s | 86.8% | 88.5% | 1.7% | San Marino |
| 1980s | 89.6% | 90.5% | 0.9% | San Marino |
| 1990s | 91.4% | 92.0% | 0.6% | San Marino |
| 2000s | 92.9% | 93.3% | 0.4% | San Marino |
| 2010s | 94.0% | 94.9% | 0.9% | San Marino |
| 2020s | 94.5% | 94.5% | 0.0% | Liechtenstein |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, female, Liechtenstein or San Marino?
- San Marino, at 95.1% against 94.6% in Liechtenstein as of 2024.
- What is the difference in survival to age 65, female between Liechtenstein and San Marino?
- 0.5%, with San Marino ahead.
- How many years of comparable data are there for Liechtenstein and San Marino?
- 65 years are reported by both, from 1960 to 2024.
- How do Liechtenstein and San Marino rank globally for survival to age 65, female?
- Liechtenstein ranks 10th and San Marino ranks 7th of 218 countries.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, female (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.